🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935
This study is a randomized, open-label, multicentric, phase III trial condu...
Status
Completed
Location
Centre Hospitalier Universitaire
Start Date
2017-03-22
Trial ID
NCT03079011
Treatments Being Tested
Fixed sequence, 2-period crossover study to compare the pharmacokinetic pro...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-09
Trial ID
NCT01918176
Treatments Being Tested
This is a Study to Evaluate the Efficacy and Safety of Multiple Combination...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center, Shanghai
Start Date
2025-06-01
Trial ID
NCT07002177
Treatments Being Tested
The primary objective of this study is to evaluate 12 weeks progression-fre...
Status
Completed
Location
UFMG - Universidade Federal de Minas Gerais
Start Date
2020-03-05
Trial ID
NCT03936270
Treatments Being Tested
The objective of this study is to estimate the effect of CYP3A4\*22 on the ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT05691400
Treatments Being Tested
Detection of molecular relapse with circulating tumour DNA analysis can ide...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2022-03-30
Trial ID
NCT04985266
Treatments Being Tested
Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (H...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-03-04
Trial ID
NCT04220476
Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (H...
Status
Recruiting
Location
Weill Cornell Medicine
Start Date
2020-11-12
Trial ID
NCT04563507